The closing date on the tender for the Australian Defence Force’s Deployable Health Capability (JP2060 Phase 3) has been extended by three weeks.
The cut off date for Phase 3 of project JP 2060, which aims to introduce an entire system (mission system), inclusive of all medical and dental equipment (a turn key solution) and designed to operate as an integrated capability, will now close on 30 November rather than 9 November.
When the RFT was released in June, Defence said the generous timeframe of the RFT is to allow for collaborative arrangements between primes and SMEs so that the full scope of the contract can be met.
The mission system for the project, in concert with support aspects (support system), is to be designed to evolve over time as health technology develops. The total integration of the acquisition and support facets of the capability from the outset is a new and innovative approach for Defence’s Deployable Health Capability (DHC).
The RFT calls for a completely deployable health facility that allows for three layers of healthcare: primary, triage and specialist.
Defence said the solution needs to include physical structures, power, water, waste disposal facility, the generation, storage and distribution of oxygen and the supply and support of all medical and dental equipment. The solution also needs to be modular, with the ability to evolve as health technology changes.
So far, Airbus and Siemens Healthineers have partnered in a teaming arrangement to jointly bid for the project, along with Saab, Aspen Medical, Philips and Marshall.
Leidos Australia has also sought out Australian SMEs to facilitate its bid for the project.